People: Eli Lilly and Co (LLY.N)
12 Dec 2013
Dr. Franklyn G. Prendergast, M.D., Ph.D., is an Independent Director of Eli Lilly & Co. He is Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School; and Director Emeritus, Mayo Clinic Center for Individualized Medicine Dr. Prendergast is the Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics at Mayo Medical School and the director emeritus of the Mayo Clinic Center for Individualized Medicine. He is an emeritus member of the Mayo Clinic board of governors and board of trustees and has held several teaching positions at the Mayo Medical School since 1975. Dr. Prendergast is a prominent medical clinician, researcher, and academician. He has experience in senior-most administration at Mayo Clinic, a medical institution, and as director of its cancer center. He has special experience in two critical areas for Lilly—oncology and personalized medicine.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|